Nuformix Income Statement

Financials in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	-	-	-	-	-	0.05
Revenue Growth (YoY)	-	-	-	-	-	-74.43%
Cost of Revenue	-	-	-	-	-	0
Gross Profit	-	-	-	-	-	0.05
Selling, General & Admin	0.63	0.66	0.51	0.62	0.76	1.32
Operating Expenses	0.63	0.66	0.51	0.62	0.76	1.32
Operating Income	-0.63	-0.66	-0.51	-0.62	-0.76	-1.27
EBT Excluding Unusual Items	-0.63	-0.66	-0.51	-0.62	-0.76	-1.27
Impairment of Goodwill	-	-	-3.14	-	-	-
Pretax Income	-0.63	-0.66	-3.65	-0.62	-0.76	-1.27
Income Tax Expense	-0.01	-0.01	-0.01	-0.05	-0	-0.16
Net Income	-0.62	-0.65	-3.64	-0.57	-0.76	-1.11
Net Income to Common	-0.62	-0.65	-3.64	-0.57	-0.76	-1.11
Shares Outstanding (Basic)	2,005	1,631	787	719	708	598
Shares Outstanding (Diluted)	2,005	1,631	787	719	708	598
Shares Change (YoY)	82.96%	107.27%	9.38%	1.58%	18.35%	3.07%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Free Cash Flow	-0.62	-0.61	-0.33	-0.4	-0.43	-1.35
Free Cash Flow Per Share	-	-	-	-0.00	-0.00	-0.00
Gross Margin	-	-	-	-	-	96.61%
Operating Margin	-	-	-	-	-	-2540.54%
Profit Margin	-	-	-	-	-	-2217.99%
Free Cash Flow Margin	-	-	-	-	-	-2691.33%
EBITDA	-0.6	-0.63	-0.48	-0.58	-0.72	-1.23
D&A For EBITDA	0.03	0.03	0.03	0.04	0.04	0.04
EBIT	-0.63	-0.66	-0.51	-0.62	-0.76	-1.27